Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Werte in diesem Artikel
A strong stock as of late has been Cardinal Health (CAH). Shares have been marching higher, with the stock up 24.7% over the past month. The stock hit a new 52-week high of $200.14 in the previous session. Cardinal has gained 66.4% since the start of the year compared to the 1.3% gain for the Zacks Medical sector and the 9.1% return for the Zacks Medical - Dental Supplies industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on October 30, 2025, Cardinal reported EPS of $2.55 versus consensus estimate of $2.21 while it beat the consensus revenue estimate by 8.39%.For the current fiscal year, Cardinal is expected to post earnings of $9.73 per share on $254.73 in revenues. This represents a 18.08% change in EPS on a 14.44% change in revenues. For the next fiscal year, the company is expected to earn $10.85 per share on $274.61 in revenues. This represents a year-over-year change of 11.46% and 7.8%, respectively.Valuation MetricsThough Cardinal has recently hit a 52-week high, what is next for Cardinal? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). The individual style scores for Value, Growth, Momentum and the combined VGM Score run from A through F. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.Cardinal has a Value Score of A. The stock's Growth and Momentum Scores are A and B, respectively, giving the company a VGM Score of A.In terms of its value breakdown, the stock currently trades at 20.2X current fiscal year EPS estimates, which is a premium to the peer industry average of 14.8X. On a trailing cash flow basis, the stock currently trades at 16.9X versus its peer group's average of 11.3X. Additionally, the stock has a PEG ratio of 1.53. This is good enough to put the company in the top echelon of all stocks we cover from a value perspective, making Cardinal an interesting choice for value investors.Zacks RankWe also need to consider the stock's Zacks Rank, as this is even more important than the company's VGM Score. Fortunately, Cardinal currently has a Zacks Rank of #2 (Buy) thanks to a solid earnings estimate revision trend.Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cardinal fits the bill. Thus, it seems as though Cardinal shares could still be poised for more gains ahead.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cardinal Health, Inc. (CAH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Cardinal Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Cardinal
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cardinal
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Cardinal Health Inc.
Analysen zu Cardinal Health Inc.
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
| 04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
| 19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
| 28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
| 04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.11.2015 | Cardinal Health Buy | UBS AG | |
| 03.11.2015 | Cardinal Health Outperform | FBR Capital | |
| 09.06.2015 | Cardinal Health Buy | UBS AG | |
| 10.03.2015 | Cardinal Health Outperform | FBR Capital | |
| 04.03.2015 | Cardinal Health Outperform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
| 04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
| 19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
| 28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
| 04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cardinal Health Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
